PECAM1 and cancer: With the observations of proliferating cell nuclear antigen (PCNA) and platelet/endothelial cell adhesion molecule-1 (PECAM-1 or CD31) results, researchers indicated the excellent performance of CL-induced y-CDs-Ce6 system in cancer therapy, providing a promising approach to achieve the selective PDT therapy (Figure 16D).